Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6162817A · kind A · utility
1Cited by
6References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2000 |
| Grant date | Dec 19, 2000 |
| Priority date | — |
| Expiry date | Jan 20, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel carbamate oxadiazolone derivatives having the general formula ##STR1## wherein R.sup.1 and R.sup.2 are as defined herein, or a nontoxic pharmaceutically acceptable salt or solvate thereof and are useful in the treatment of disorders which are responsive to the opening of the large conductance calcium-activated potassium channels.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.